Key facts
- Balyasny Asset Management is a hedge fund based in 303 Colorado Street, Suite 1900 with 8 tracked portfolio companies.
- Notable positions include Forterra, Diagonal Therapeutics, Solve Therapeutics, Aspen Neuroscience, TRexBio.
- The team roster lists 23 people.
- Balyasny Asset Management reports $138.8B in regulatory assets under management across 38 private funds, per its SEC Form ADV (2026-03).
About Balyasny Asset Management
Founded in 2001, Balyasny Asset Management is a long/short equity hedge fund manager based in Austin, Texas. The firm employs a strategy in equities, macro, and commodities.
Registered with the SEC
Form ADV · 2026-03 · CRD 138111- Regulatory AUM
- $138.8B
- Private fund assets
- $277.6B
- Private funds
- 38 · 1 venture, 3 private equity, 34 hedge
- Staff
- 2434
- Registered office
- CHICAGO, IL
- SEC status
- Approved
Discloses a disciplinary history on Form ADV. Reports custody of client assets.
Source: SEC Investment Adviser Public Disclosure, Form ADV (registered as BALYASNY ASSET MANAGEMENT L.P.).
Free account
See the whole book
- ·Watchlist + alerts for Balyasny Asset Management's activity
Create free account
No card required
Portfolio, priced
8 companies · by our current valuations| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| Forterra | Aerospace and Defense | $1.0B | — | |
| Diagonal Therapeutics | Drug Discovery | $458.5M | — | |
| Solve Therapeutics | — | $439.0M | — | |
| Aspen Neuroscience | — | $346.0M | — | |
| TRexBio | — | $274.0M | — | |
| Ambros Therapeutics | Biotechnology | $250.0M | — | |
| Expedition Therapeutics | — | $221.0M | — | |
| Astranis | Aerospace and Defense | — | — |
Team
23 people on record — 23 with verified contacts
Partners, principals, and the people who answer a pitch. Pro members reveal contacts with credits.
Frequently asked
- What companies does Balyasny Asset Management invest in?
- Balyasny Asset Management has 8 recorded portfolio companies, including Forterra, Diagonal Therapeutics, Solve Therapeutics, Aspen Neuroscience.
- What is Balyasny Asset Management's AUM?
- Balyasny Asset Management manages approximately $265.1B in assets.